Literature DB >> 32862458

Critical review of non-histone human substrates of metal-dependent lysine deacetylases.

Tasha B Toro1, Terry J Watt1.   

Abstract

Lysine acetylation is a posttranslational modification that occurs on thousands of human proteins, most of which are cytoplasmic. Acetylated proteins are involved in numerous cellular processes and human diseases. Therefore, how the acetylation/deacetylation cycle is regulated is an important question. Eleven metal-dependent lysine deacetylases (KDACs) have been identified in human cells. These enzymes, along with the sirtuins, are collectively responsible for reversing lysine acetylation. Despite several large-scale studies which have characterized the acetylome, relatively few of the specific acetylated residues have been matched to a proposed KDAC for deacetylation. To understand the function of lysine acetylation, and its association with diseases, specific KDAC-substrate pairs must be identified. Identifying specific substrates of a KDAC is complicated both by the complexity of assaying relevant activity and by the non-catalytic interactions of KDACs with cellular proteins. Here, we discuss in vitro and cell-based experimental strategies used to identify KDAC-substrate pairs and evaluate each for the purpose of directly identifying non-histone substrates of metal-dependent KDACs. We propose criteria for a combination of reproducible experimental approaches that are necessary to establish a direct enzymatic relationship. This critical analysis of the literature identifies 108 proposed non-histone substrate-KDAC pairs for which direct experimental evidence has been reported. Of these, five pairs can be considered well-established, while another thirteen pairs have both cell-based and in vitro evidence but lack independent replication and/or sufficient cell-based evidence. We present a path forward for evaluating the remaining substrate leads and reliably identifying novel KDAC substrates.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  HDAC; KDAC; histone deacetylases; substrate specificity

Year:  2020        PMID: 32862458      PMCID: PMC7719617          DOI: 10.1096/fj.202001301RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  120 in total

Review 1.  Acetylation of non-histone proteins modulates cellular signalling at multiple levels.

Authors:  Stephanie Spange; Tobias Wagner; Thorsten Heinzel; Oliver H Krämer
Journal:  Int J Biochem Cell Biol       Date:  2008-09-02       Impact factor: 5.085

2.  Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin.

Authors:  David Kaluza; Jens Kroll; Sabine Gesierich; Tso-Pang Yao; Reinier A Boon; Eduard Hergenreider; Marc Tjwa; Lothar Rössig; Edward Seto; Hellmut G Augustin; Andreas M Zeiher; Stefanie Dimmeler; Carmen Urbich
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

3.  Acetylation site specificities of lysine deacetylase inhibitors in human cells.

Authors:  Christian Schölz; Brian T Weinert; Sebastian A Wagner; Petra Beli; Yasuyuki Miyake; Jun Qi; Lars J Jensen; Werner Streicher; Anna R McCarthy; Nicholas J Westwood; Sonia Lain; Jürgen Cox; Patrick Matthias; Matthias Mann; James E Bradner; Chunaram Choudhary
Journal:  Nat Biotechnol       Date:  2015-03-09       Impact factor: 54.908

4.  Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy.

Authors:  M Gupta; J J Han; M Stenson; L Wellik; T E Witzig
Journal:  Leukemia       Date:  2011-11-25       Impact factor: 11.528

5.  Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.

Authors:  Purva Bali; Michael Pranpat; James Bradner; Maria Balasis; Warren Fiskus; Fei Guo; Kathy Rocha; Sandhya Kumaraswamy; Sandhya Boyapalle; Peter Atadja; Edward Seto; Kapil Bhalla
Journal:  J Biol Chem       Date:  2005-06-02       Impact factor: 5.157

6.  Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer.

Authors:  Y-W Chang; C-F Tseng; M-Y Wang; W-C Chang; C-C Lee; L-T Chen; M-C Hung; J-L Su
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

7.  Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1.

Authors:  Hisako Higashitsuji; Hiroaki Higashitsuji; Tomoko Masuda; Yu Liu; Katsuhiko Itoh; Jun Fujita
Journal:  J Biol Chem       Date:  2007-03-12       Impact factor: 5.157

8.  NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.

Authors:  Paola Bendinelli; Emanuela Matteucci; Paola Maroni; Maria Alfonsina Desiderio
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

9.  CPLA 1.0: an integrated database of protein lysine acetylation.

Authors:  Zexian Liu; Jun Cao; Xinjiao Gao; Yanhong Zhou; Longping Wen; Xiangjiao Yang; Xuebiao Yao; Jian Ren; Yu Xue
Journal:  Nucleic Acids Res       Date:  2010-11-08       Impact factor: 16.971

10.  Class IIa histone deacetylases are conserved regulators of circadian function.

Authors:  Paul C M Fogg; John S O'Neill; Tomasz Dobrzycki; Shaun Calvert; Emma C Lord; Rebecca L L McIntosh; Christopher J H Elliott; Sean T Sweeney; Michael H Hastings; Sangeeta Chawla
Journal:  J Biol Chem       Date:  2014-09-30       Impact factor: 5.157

View more
  1 in total

1.  Lysine Deacetylase Substrate Selectivity: A Dynamic Ionic Interaction Specific to KDAC8.

Authors:  Tasha B Toro; Jordan S Swanier; Jada A Bezue; Christian G Broussard; Terry J Watt
Journal:  Biochemistry       Date:  2021-08-06       Impact factor: 3.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.